Bunion Correction Systems Market Size, Growth, Trends | Report 2022-2030
Bunion correction systems are used to treat a bunion, a foot deformity affecting the metatarsophalangeal joint. Bunions are caused due to inherited foot structure problems; foot injuries or inflammatory diseases such as rheumatoid arthritis.More than 20% of men and women aged between 18-65 suffer from bunions, and more than 35% of men and women over the age of 65 years suffer from toe deformity. Also, the condition is more common in women due to the differences in foot anatomy, footwear, and genetic influence. The rising prevalence of bunion in the overall population is the major factor driving the market.
According to the American Orthopaedic Foot and Ankle Society, about one-third of women have bunions. Also, as per the National Institutes of Health (NIH), a bunion is likely to appear among 23 out of 100 adults across the globe and a prevalence of 8 % to 36% is observed among the pediatric population.
The changing lifestyle and increasing women working population have raised the risk of bunion (hallux valgus), thereby accelerating the demand for bunion treatment. In the U.S., around 150,000 bunion procedures are performed every year. This is expected to further drive the market for bunion correction systems. Furthermore, increasing approvals of different correction system is further boosting the market. For instance, in May 2019, FDA approved Lapiplasty 3D Bunion Correction System for use in pediatric patients.
Some of the key players in the market are Stryker Corporation,Arthrex, Inc., Zimmer Biomet Holdings, Inc.,Wright Medical Technology, Inc,Extremity Medical, LLC.,Acumed, LLC, De Puy Synthes, Biomet, Inc., CrossRoads Extremity Systems, BioPro, Inc., Orthofix Holdings Inc., OrthoHelix Surgical Designs, etc. These players are focusing on the development of innovative correction systems, thereby impelling the market. For instance, in January 2021, the 4D minimally-invasive DynaBunion Lapidus System was launched by CrossRoads Extremity Systems for surgical bunion repair. This 4D system helps to restore normal foot anatomy by realigning and fusing the bones in 4 different dimensions through small incisions.
The commonly used products for bunion correction include wearables and implants. The wearable products for bunion correction include splints that help to keep the toe straight by supporting it from the side. It is usually designed for overnight wear. The implants are inserted through a small incision to anchor at the base of the metatarsal to the cuneiform bone which helps to fuse it, thereby correcting the joint.
Market Segmentation
By Product Outlook
By End-Use Outlook
By Regional Outlook
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Bunion Correction Systems Market
5.1. COVID-19 Landscape: Bunion Correction Systems Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Bunion Correction Systems Market, By Product
8.1. Bunion Correction Systems Market, by Product, 2022-2030
8.1.1. Implants
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Wearables
8.1.2.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Bunion Correction Systems Market, By End-Use
9.1. Bunion Correction Systems Market, by End-Use, 2022-2030
9.1.1. Hospitals
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Ambulatory Centers
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Clinics
9.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Bunion Correction Systems Market, Regional Estimates and Trend Forecast
10.1. North America
10.1.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.1.3. U.S.
10.1.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.1.4. Rest of North America
10.1.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.1.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2. Europe
10.2.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.3. UK
10.2.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.4. Germany
10.2.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.5. France
10.2.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.2.6. Rest of Europe
10.2.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.2.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3. APAC
10.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.3. India
10.3.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.4. China
10.3.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.5. Japan
10.3.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.3.6. Rest of APAC
10.3.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.3.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4. MEA
10.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.3. GCC
10.4.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.4. North Africa
10.4.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.5. South Africa
10.4.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.4.6. Rest of MEA
10.4.6.1. Market Revenue and Forecast, by Product (2017-2030)
10.4.6.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5. Latin America
10.5.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5.3. Brazil
10.5.3.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.3.2. Market Revenue and Forecast, by End-Use (2017-2030)
10.5.4. Rest of LATAM
10.5.4.1. Market Revenue and Forecast, by Product (2017-2030)
10.5.4.2. Market Revenue and Forecast, by End-Use (2017-2030)
Chapter 11. Company Profiles
11.1. Stryker Corporation
11.1.1. Company Overview
11.1.2. Product Offerings
11.1.3. Financial Performance
11.1.4. Recent Initiatives
11.2. Arthrex, Inc.
11.2.1. Company Overview
11.2.2. Product Offerings
11.2.3. Financial Performance
11.2.4. Recent Initiatives
11.3. Zimmer Biomet Holdings, Inc.
11.3.1. Company Overview
11.3.2. Product Offerings
11.3.3. Financial Performance
11.3.4. Recent Initiatives
11.4. Wright Medical Technology, Inc
11.4.1. Company Overview
11.4.2. Product Offerings
11.4.3. Financial Performance
11.4.4. LTE Scientific
11.5. Extremity Medical, LLC.
11.5.1. Company Overview
11.5.2. Product Offerings
11.5.3. Financial Performance
11.5.4. Recent Initiatives
11.6. Acumed, LLC
11.6.1. Company Overview
11.6.2. Product Offerings
11.6.3. Financial Performance
11.6.4. Recent Initiatives
11.7. De Puy Synthes
11.7.1. Company Overview
11.7.2. Product Offerings
11.7.3. Financial Performance
11.7.4. Recent Initiatives
11.8. Biomet, Inc.
11.8.1. Company Overview
11.8.2. Product Offerings
11.8.3. Financial Performance
11.8.4. Recent Initiatives
11.9. CrossRoads Extremity Systems
11.9.1. Company Overview
11.9.2. Product Offerings
11.9.3. Financial Performance
11.9.4. Recent Initiatives
11.10. BioPro, Inc.
11.10.1. Company Overview
11.10.2. Product Offerings
11.10.3. Financial Performance
11.10.4. Recent Initiatives
Chapter 12. Research Methodology
12.1. Primary Research
12.2. Secondary Research
12.3. Assumptions
Chapter 13. Appendix
13.1. About Us
13.2. Glossary of Terms
Cross-segment Market Size and Analysis for
Mentioned Segments
Additional Company Profiles (Upto 5 With No Cost)
Additional Countries (Apart From Mentioned Countries)
Country/Region-specific Report
Go To Market Strategy
Region Specific Market DynamicsRegion Level Market Share Import Export AnalysisProduction AnalysisOthers